• DOI:10.1136/gut.2010.222893
Corpus ID: 25614617

Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study

@article{Coelho2010PregnancyOI,
  title={Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study},
  author={J. Coelho and L. Beaugerie and J. Colombel and X. H{\'e}buterne and {\'E}. Lerebours and M. L{\'e}mann and P. Baumer and J. Cosnes and A. Bourreille and J. Gendre and P. Seksik and A. Blain and E. Metman and A. Nisard and G. Cadiot and M. Veyrac and B. Coffin and X. Dray and F. Carrat and P. Marteau},
  journal={Gut},
  year={2010},
  volume={60},
  pages={198 - 203}
}

• J. Coelho, L. Beaugerie, +17 authors P. Marteau
• Published 2010
• Medicine
• Gut

Background and aims Few studies have been conducted addressing the safety of thiopurine treatment in pregnant women with inflammatory bowel disease (IBD). The aim of this study was to evaluate the pregnancy outcome of women with IBD who have been exposed to thiopurines. Methods 215 pregnancies in 204 women were registered and documented in the CESAME cohort between May 2004 and October 2007. Physicians documented the following information from the women: last menstrual date, delivery term… Expand

View on BMJ Group

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed